SCHEMBL8137679

SCHEMBL8137679

CCOc1cc(C=O)cc(OCC)n1

nearest known ligand 0.44

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.44
KDM4E B2RXH2 2/20 0.41
NPC1 O15118 1/20 0.41
MAPK1 P28482 1/20 0.41
RAB9A P51151 1/20 0.41
GAA P10253 1/20 0.40
LMNA P02545 2/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.38
MAPT P10636 1/20 0.38
TACR2 P21452 1/20 0.36
BTK Q06187 1/20 0.35
EDNRB P24530 1/20 0.35
EDNRA P25101 1/20 0.35
DHFR P00374 1/20 0.35
FDPS P14324 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7399408 0.79 ALDH1A1 (0.49) ALDH1A1KDM4EGAALMNAL3MBTL1
SCHEMBL11200168 0.77 ALDH1A1 (0.47) ALDH1A1KDM4ENPC1MAPK1RAB9A
SCHEMBL1618933 0.76 ALDH1A1 (0.47) ALDH1A1KDM4ENPC1RAB9ALMNA
SCHEMBL5883815 0.74 ALDH1A1 (0.47) ALDH1A1KDM4ELMNAL3MBTL1SMN1; SMN2
SCHEMBL273282 0.74 ALDH1A1 (0.47) ALDH1A1KDM4ELMNAL3MBTL1SMN1; SMN2
SCHEMBL933951 0.73 KDM4E (0.57) ALDH1A1KDM4ELMNAL3MBTL1SMN1; SMN2
SCHEMBL89165 0.73 FDPS (0.38) ALDH1A1KDM4ENPC1RAB9ALMNA
SCHEMBL8386822 0.73 TSHR (0.45) ALDH1A1KDM4ENPC1RAB9AGAA
SCHEMBL4469982 0.73 SMN1; SMN2 (0.46) ALDH1A1NPC1MAPK1RAB9ALMNA
SCHEMBL7464556 0.73 ALDH1A1 (0.55) ALDH1A1KDM4ENPC1MAPK1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1115330-C N- (4-amidinophenyl) glycinamide derivatives HOFFMANN LA ROCHE (CH) 2003-07-23 CN disclosed
US-6140353-A USED AS MEDICAMENTS FOR THE TREATMENT AND/OR PREVENTION OF THROMBOSES, APOPLEXY, CARDIAC INFARCTION, INFLAMMATION AND ARTERIOSCLEROSIS OR AS ANTITUMOR AGENTS HOFFMANN-LA ROCHE INC. (US) 2000-10-31 US disclosed
CN-1224714-A N- (4-amidinophenyl) glycinamide derivatives HOFFMANN LA ROCHE (CH) 1999-08-04 CN disclosed